Health Sciences Institute e-Alert Archives

Our daily e-letter, known as e-Alert, delivers health news—before anyone else. From overlooked studies to underground cures, it’s all here. Catch up on the insights that matter most.

Every weekday, our FREE e-Alert delivers urgent health breakthroughs and hidden dangers—before they hit the headlines.

Not signed up yet? Join 500,000+ readers worldwide by using the sign-up box below.

FILTERS
applied to search results for “Prescription Drug and FDA”

YEAR

CATEGORY

Browse the FULL e-Alert Archive using the filters in this section, or search for a specific topic below:


Search Results for “Prescription Drug and FDA” (493 results found)

Conquer urinary incontinence in days with this modern ancient 11-herb formula

April 5, 2017 by Michele Cagan No matter what your doctor has told you... and that’s if you talked to a doctor at all... It’s not a normal part of aging. Unfortunately, due to some under-informed doctors and some very convincing advertising, most of us believe that urinary incontinence is just something we... Read More >

Categories: nl-2017-04
Newsletter Issue: April 2017

Taking these meds for a cold triples your heart attack risk

March 30, 2017 It’s the first thing you might reach for if you have a cold or the flu — one of those OTC painkillers known as NSAIDS. Even the Mayo Clinic has them on a list of things to do for the common cold that “can’t hurt.” Unfortunately, they can hurt —... Read More >

Categories: colds dangers of NSAIDs flu heart attack risk NSAIDs risks of anti-inflammatory drugs

This ‘miracle drug’ is really nothing but a dangerous dud

March 27, 2017 The way the media is telling the story, it’s your money... or your life. Fork over around $14K a year for the “miracle” cholesterol drug Repatha — or somehow convince your insurance company to cover the injection — and you can stop a deadly heart attack or stroke in its... Read More >

Categories: Amgen cholesterol dementia FDA PCSK9 inhibitors Repatha Repatha and dementia study on Repatha

The biggest risk you take filling an Rx isn’t what you think

March 20, 2017 If you go to your doctor for help with insomnia, you’re more likely than not to leave with an Rx. And the chances are good it will be for one of the most commonly-prescribed drugs for sleeping problems — trazodone. But trazodone is a med that was approved by the... Read More >

Categories: antidepressants antidepressants used off label FDA Off-label drugs trazodone and insomnia Zoloft

Going ‘off-label’ can put you on the fast track to dementia

March 2, 2017 How to fast-track yourself towards dementia in two easy steps: Step #1: See your doctor about some “senior moments” you’ve been having. Step #2: Fill his prescription for a med that was approved for a different condition — one that’s far worse than whatever you’re experiencing (as worrisome as it... Read More >

Categories: Alzheimer’s disease Aricept dementia FDA MCI mild cognitive impairment off label prescribing

More and more seniors prescribed death-row drug combos

February 27, 2017 A new study just published in JAMA is sounding the alarm about seniors and drugs like never before. It appears that more and more of them are being prescribed a killer cocktail of meds. Despite all the warnings — and despite doctors pledging to be more careful — things are... Read More >

Categories: benzos opioids Psychotropic drugs risky drug combos study seniors psychiatric drugs University of Michigan study psychotropic drugs

FDA ignores horrific results of giving this med to children

February 13, 2017 Last week I told you about a barbaric therapy used to treat men with prostate cancer called androgen deprivation therapy (ADT). In adult men, it’s been known to cause side effects such as bone fractures, heart attacks, strokes and sudden death. But one of these ADT drugs, called Lupron, isn’t... Read More >

Categories: ADT androgen deprivation therapy dangers of Lupron Lupron precocious puberty prostate cancer

How drug trials are often engineered to hide the truth

January 24, 2017 “Money talks” may be a hackneyed expression, but it’s truer than ever — especially when it comes to drug trials. The use of clinical trials is one of the primary ways the FDA decides if a drug is safe and effective and if it ends up on the pharmacy shelf... Read More >

Categories: big pharma deceptive drug trials Drug studies FDA manipulated drug studies Tamiflu

How to stay safe from germs antibiotics can no longer kill

January 18, 2017 This past week, I wasn’t sure if I was reading the news... or the plot of a horror movie. But unfortunately, it was all too real. Reports of a Nevada woman who died from an infection that was resistant to every single antibiotic available in the United States were not... Read More >

Categories: antibiotic resistant bacteria CRE bacteria how to stay safe from superbugs superbug infections superbugs

Is your heartburn med setting you up for a fatal infection?

January 11, 2017 It’s hard to believe that a class of drugs that can do so much harm can be so easy to obtain. I’m talking about those acid-reducing meds that are sold everywhere — and, for the most part, without a prescription. And when I say cause harm, I’m referring to some... Read More >

Categories: acid blockers C. diff infections campylobacter H2 blockers Nexium Pepcid PPIs Prilosec side effects of acid blocking drugs Zantac

What’s the real reason for the decline in life expectancy?

December 15, 2016 More Americans than ever have kicked their smoking habit. We’re more active, too. A recent Gallup poll found that over 50 percent of Americans are doing some type of exercise three or more times a week! That’s the good news. And the bad? The life expectancy in the U.S. has... Read More >

Categories: Alzheimer’s big pharma Diabetes FDA heart disease kidney disease life expectancy drops in the U.S. statins and diabetes type 2 diabetes U.S. life expectancy

Another new cholesterol-lowering med may be riskiest yet

December 13, 2016 Of all the crazy tricks Big Pharma has tried to pull for the purpose of lowering our cholesterol, this is the boldest — and most dangerous — stunt yet. I thought I had seen everything, but then Inclisiran came along. And you need to know about it now, before it... Read More >

Categories: big pharma cholesterol danger of too-low cholesterol Inclisiran PCSK9 inhibitors statins why we need cholesterol
Allan Spreen, M.D.
Dr. Allan Spreen, Chief Medical Advisor

Meet the Health Sciences Institute

The Health Sciences Institute (HSI) is an independent organization established in 1998. We’re dedicated to uncovering and researching the most urgent advances in modern underground medicine. Things you WON’T hear about in the mainstream.

Whether they come from a laboratory in Malaysia, a clinic in South America, or a university in Germany, our goal is to bring the treatments that work directly to the people who need them. We alert our Members to exciting breakthroughs in medicine, show them exactly where to go to learn more, and help them understand how they and their families can benefit from these powerful discoveries.

Learn More About the Health Sciences Institute. >